Medicare looks at expanding coverage for Visudyne
This article was originally published in Clinica
Executive Summary
The Medicare Coverage Advisory Committee (MCAC) has recommended that Medicare expand its coverage of Visudyne therapy to include an additional category of patients with age-related macular degeneration.